Medinex Ltd.

As of March 31, 2026, Medinex Ltd. carries a market capitalization of 30.27M, placing it among publicly traded companies globally. Its enterprise value stands at 25.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Medinex Ltd. has 134.54M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Medinex Ltd. maintains a current ratio of 3.50, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 15, 2026, Medinex Ltd.'s stock has declined approximately 14.89% over the past 52 weeks. The 50-day moving average sits at 0.22, while the 200-day moving average is 0.23.

As of March 31, 2026, Medinex Ltd. holds 5.52M in cash and equivalents against 995,706.00 in total debt, resulting in a net debt position of -3.26M. Total book value stands at 16.52M, with working capital of 6.06M providing operational flexibility.